Cite
HARVARD Citation
Zimmerman, O. et al. (2017). Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease. Open forum infectious diseases. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zimmerman, O. et al. (2017). Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease. Open forum infectious diseases. p. . [Online].